Nonbacterial thrombotic endocarditis in cancer patients: Pathogenesis, diagnosis, and treatment

Khaled El-Shami, Elizabeth Griffiths, Michael Streiff

Research output: Contribution to journalReview articlepeer-review

Abstract

Thrombophilia is a well-described consequence of cancer and its treatment. The pathogenesis of this phenomenon is complex and multifactorial. Nonbacterial thrombotic endocarditis (NBTE) is a serious and potentially underdiagnosed manifestation of this prothrombotic state that can cause substantial morbidity in affected patients, most notably recurrent or multiple ischemic cerebrovascular strokes. Diagnosis of NBTE requires a high degree of clinical suspicion as well as the judicious use of two-dimensional echocardiography to document the presence of valvular thrombi. In the absence of contraindications to therapy, treatment consists of systemic anticoagulation, which may ameliorate symptoms and prevent further thromboembolic episodes, as well as control of the underlying malignancy whenever possible.

Original languageEnglish (US)
Pages (from-to)518-523
Number of pages6
JournalOncologist
Volume12
Issue number5
DOIs
StatePublished - 2007

Keywords

  • Anticoagulation
  • Cancer
  • Nonbacterial thrombotic endocarditis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Nonbacterial thrombotic endocarditis in cancer patients: Pathogenesis, diagnosis, and treatment'. Together they form a unique fingerprint.

Cite this